Literature DB >> 4713126

Lysozyme content of amniotic fluid.

S H Cherry, M Filler, H Harvey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4713126     DOI： 10.1016/s0002-9378(15)33127-6

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN： 0002-9378            Impact factor:   8.661


× No keyword cloud information.
  6 in total

1.  The maternal plasma proteome changes as a function of gestational age in normal pregnancy: a longitudinal study.

Authors:  Roberto Romero; Offer Erez; Eli Maymon; Piya Chaemsaithong; Zhonghui Xu; Percy Pacora; Tinnakorn Chaiworapongsa; Bogdan Done; Sonia S Hassan; Adi L Tarca
Journal:  Am J Obstet Gynecol       Date:  2017-03-03       Impact factor: 8.661

2.  Isolation of a low-molecular-weight antibacterial system from human amniotic fluid.

Authors:  P Schlievert; W Johnson; R P Galask
Journal:  Infect Immun       Date:  1976-11       Impact factor: 3.441

3.  Antibacterial activity of amniotic fluid against Staphylococcus aureus, Candida albicans and Brucella abortus.

Authors:  R P Jankowski; H E Aikins; H Vahrson; K G Gupta
Journal:  Arch Gynakol       Date:  1977-05-29

4.  Human beta-defensin-2: a natural antimicrobial peptide present in amniotic fluid participates in the host response to microbial invasion of the amniotic cavity.

Authors:  Eleazar Soto; Jimmy Espinoza; Jyh Kae Nien; Juan Pedro Kusanovic; Offer Erez; Karina Richani; Joaquin Santolaya-Forgas; Roberto Romero
Journal:  J Matern Fetal Neonatal Med       Date:  2007-01

5.  Differential expression pattern of genes encoding for anti-microbial peptides in the fetal membranes of patients with spontaneous preterm labor and intact membranes and those with preterm prelabor rupture of the membranes.

Authors:  Offer Erez; Roberto Romero; Adi L Tarca; Tinnakorn Chaiworapongsa; Yeon Mee Kim; Nandor Gabor Than; Edi Vaisbuch; Sorin Draghici; Gerard Tromp
Journal:  J Matern Fetal Neonatal Med       Date:  2009-12

Review 6.  Mucosal Immune Development in Early Life: Setting the Stage.

Authors:  Sylvia Brugman; Olaf Perdijk; R J Joost van Neerven; Huub F J Savelkoul
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2015-02-11       Impact factor: 4.291
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.